Jeremy Green - Net Worth and Insider Trading
Jeremy Green Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeremy Green owns 35 companies in total, including Shattuck Labs Inc (STTK) , IGM Biosciences Inc (IGMS) , and Kymera Therapeutics Inc (KYMR) among others .
Click here to see the complete history of Jeremy Green’s form 4 insider trades.
Insider Ownership Summary of Jeremy Green
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
STTK | Shattuck Labs Inc | 2020-10-08 | director & 10 percent owner |
IGMS | IGM Biosciences Inc | 2020-02-05 | 10 percent owner |
KYMR | Kymera Therapeutics Inc | 2020-08-20 | 10 percent owner |
2020-07-29 | 10 percent owner | ||
2020-07-23 | 10 percent owner | ||
2020-07-23 | 10 percent owner | ||
2020-06-18 | 10 percent owner | ||
2020-05-01 | director & 10 percent owner | ||
2020-06-02 | 10 percent owner | ||
2020-03-26 | 10 percent owner | ||
2020-02-05 | 10 percent owner | ||
2019-10-24 | 10 percent owner | ||
2019-10-22 | director | ||
2020-12-28 | 10 percent owner | ||
2019-06-19 | 10 percent owner | ||
2019-06-19 | 10 percent owner | ||
2019-06-18 | 10 percent owner | ||
2019-04-17 | 10 percent owner | ||
2019-02-19 | 10 percent owner | ||
2019-02-13 | 10 percent owner | ||
2018-11-13 | 10 percent owner | ||
2018-09-27 | 10 percent owner | ||
2018-07-19 | 10 percent owner | ||
2018-07-18 | 10 percent owner | ||
2016-06-29 | 10 percent owner | ||
2016-06-03 | 10 percent owner | ||
2020-11-17 | director & 10 percent owner | ||
2021-07-21 | director & 10 percent owner | ||
2021-10-28 | 10 percent owner | ||
2020-10-05 | director & 10 percent owner | ||
2021-10-06 | director & 10 percent owner | ||
2021-08-05 | 10 percent owner | ||
2021-06-16 | 10 percent owner | ||
2022-10-13 | 10 percent owner | ||
2023-09-14 | 10 percent owner |
Jeremy Green Trading Performance
Jeremy Green Ownership Network
Jeremy Green Owned Company Details
What does Shattuck Labs Inc do?
Who are the key executives at Shattuck Labs Inc?
Jeremy Green is the director & 10 percent owner of Shattuck Labs Inc. Other key executives at Shattuck Labs Inc include See Remarks Stephen Stout , See Remarks Andrew R Neill , and Chief Technical Officer Abhinav A. Shukla .
Shattuck Labs Inc (STTK) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Shattuck Labs Inc (STTK). Other recent insider transactions involving Shattuck Labs Inc (STTK) include a net sale of 25,000 shares made by Andrew R Neill , and a net sale of 16,004 shares made by Stephen Stout .
In summary, during the past 3 months, insiders sold 16,004 shares of Shattuck Labs Inc (STTK) in total and bought 0 shares, with a net sale of 16,004 shares. During the past 18 months, 41,004 shares of Shattuck Labs Inc (STTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 41,004 shares.
Shattuck Labs Inc (STTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shattuck Labs Inc Insider Transactions
- Download to Excel(.xls)
What does IGM Biosciences Inc do?
Who are the key executives at IGM Biosciences Inc?
Jeremy Green is the 10 percent owner of IGM Biosciences Inc. Other key executives at IGM Biosciences Inc include director & 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Steven Weber , and Chief Medical Officer Chris H Takimoto .
IGM Biosciences Inc (IGMS) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in IGM Biosciences Inc (IGMS). Other recent insider transactions involving IGM Biosciences Inc (IGMS) include a net sale of 11,918 shares made by George Gauthier , a net sale of 20,975 shares made by Bruce Keyt , and a net sale of 14,987 shares made by Lisa Lynn Decker .
In summary, during the past 3 months, insiders sold 28,125 shares of IGM Biosciences Inc (IGMS) in total and bought 395,317 shares, with a net purchase of 367,192 shares. During the past 18 months, 204,745 shares of IGM Biosciences Inc (IGMS) were sold and 1,130,933 shares were bought by its insiders, resulting in a net purchase of 926,188 shares.
IGM Biosciences Inc (IGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
IGM Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Kymera Therapeutics Inc do?
Who are the key executives at Kymera Therapeutics Inc?
Jeremy Green is the 10 percent owner of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include 10 percent owner Atlas Venture Fund X, L.p. , Chief Medical Officer Jared Gollob , and Chief Financial Officer Bruce N. Jacobs .
Kymera Therapeutics Inc (KYMR) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 989,618 shares made by Bruce Booth , a net sale of 862,075 shares made by Atlas Venture Fund X, L.p. , and a net sale of 49,881 shares made by Jared Gollob .
In summary, during the past 3 months, insiders sold 846,935 shares of Kymera Therapeutics Inc (KYMR) in total and bought 0 shares, with a net sale of 846,935 shares. During the past 18 months, 1,925,173 shares of Kymera Therapeutics Inc (KYMR) were sold and 455,112 shares were bought by its insiders, resulting in a net sale of 1,470,061 shares.
Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kymera Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does AlloVir Inc do?
Who are the key executives at AlloVir Inc?
Jeremy Green is the 10 percent owner of AlloVir Inc. Other key executives at AlloVir Inc include director & 10 percent owner & See Remarks Vikas Sinha , General Counsel Edward Miller , and Chief Accounting Officer Brett R Hagen .
AlloVir Inc (ALVR) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in AlloVir Inc (ALVR). Other recent insider transactions involving AlloVir Inc (ALVR) include a net sale of 185,237 shares made by Diana Brainard , a net sale of 61,127 shares made by Brett R Hagen , and a net sale of 65,916 shares made by Vikas Sinha .
In summary, during the past 3 months, insiders sold 49,511 shares of AlloVir Inc (ALVR) in total and bought 0 shares, with a net sale of 49,511 shares. During the past 18 months, 329,895 shares of AlloVir Inc (ALVR) were sold and 2,930,870 shares were bought by its insiders, resulting in a net purchase of 2,600,975 shares.
AlloVir Inc (ALVR)'s detailed insider trading history can be found in Insider Trading Tracker table.
AlloVir Inc Insider Transactions
- Download to Excel(.xls)
What does Annexon Inc do?
Who are the key executives at Annexon Inc?
Jeremy Green is the 10 percent owner of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Financial Officer Jennifer Lew , EVP & Chief Innovation Officer Ted Yednock , and EVP & Chief Business Officer Michael Overdorf .
Annexon Inc (ANNX) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 47,471 shares made by Ted Yednock , a net sale of 7,367 shares made by Jennifer Lew , and a net sale of 5,923 shares made by Michael Overdorf .
In summary, during the past 3 months, insiders sold 7,148 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 748 shares. During the past 18 months, 73,114 shares of Annexon Inc (ANNX) were sold and 3,303,458 shares were bought by its insiders, resulting in a net purchase of 3,230,344 shares.
Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Annexon Inc Insider Transactions
- Download to Excel(.xls)
What does Nurix Therapeutics Inc do?
Who are the key executives at Nurix Therapeutics Inc?
Jeremy Green is the 10 percent owner of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include Chief Financial Officer Houte Hans Van , General Counsel Christine Ring , and Chief Scientific Officer Gwenn Hansen .
Nurix Therapeutics Inc (NRIX) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 31,786 shares made by Houte Hans Van , a net sale of 10,406 shares made by Gwenn Hansen , and a net sale of 7,455 shares made by Christine Ring .
In summary, during the past 3 months, insiders sold 8,406 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 8,406 shares. During the past 18 months, 50,413 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 50,413 shares.
Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nurix Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Repare Therapeutics Inc do?
Who are the key executives at Repare Therapeutics Inc?
Jeremy Green is the 10 percent owner of Repare Therapeutics Inc. Other key executives at Repare Therapeutics Inc include EVP & Chief Medical Officer Maria Koehler , EVP & Chief Science Officer Michael Zinda , and EVP & Chief Financial Officer Steve Forte .
Repare Therapeutics Inc (RPTX) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .
In summary, during the past 3 months, insiders sold 21,690 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 21,690 shares. During the past 18 months, 282,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,728,847 shares.
Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Repare Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Fate Therapeutics Inc do?
Who are the key executives at Fate Therapeutics Inc?
Jeremy Green is the director & 10 percent owner of Fate Therapeutics Inc. Other key executives at Fate Therapeutics Inc include Chief Financial Officer Dulac Edward J Iii , director & President and CEO J Scott Wolchko , and Chief Development Officer Bahram Valamehr .
Fate Therapeutics Inc (FATE) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 26,108 shares made by Dulac Edward J Iii , a net purchase of 44,630 shares made by Redmile Group, Llc , and a net sale of 46,790 shares made by Cindy Tahl .
In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 479,444 shares of Fate Therapeutics Inc (FATE) were sold and 471,648 shares were bought by its insiders, resulting in a net sale of 7,796 shares.
Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fate Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Pliant Therapeutics Inc do?
Who are the key executives at Pliant Therapeutics Inc?
Jeremy Green is the 10 percent owner of Pliant Therapeutics Inc. Other key executives at Pliant Therapeutics Inc include Chief Business Officer Hans Hull , Chief Medical Officer Eric Lefebvre , and Chief Financial Officer Keith Lamont Cummings .
Pliant Therapeutics Inc (PLRX) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Pliant Therapeutics Inc (PLRX). Other recent insider transactions involving Pliant Therapeutics Inc (PLRX) include a net sale of 405,422 shares made by Bernard Coulie , a net sale of 58,128 shares made by Mike Ouimette , and a net sale of 122,248 shares made by Eric Lefebvre .
In summary, during the past 3 months, insiders sold 0 shares of Pliant Therapeutics Inc (PLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 745,379 shares of Pliant Therapeutics Inc (PLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 745,379 shares.
Pliant Therapeutics Inc (PLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pliant Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Neoleukin Therapeutics Inc do?
Who are the key executives at Neoleukin Therapeutics Inc?
Jeremy Green is the 10 percent owner of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .
Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net sale of 18,149 shares made by Priti Patel , a net sale of 4,639 shares made by Sean Michael Smith , and a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp .
In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,139 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 113,128 shares.
Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neoleukin Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Beam Therapeutics Inc do?
Who are the key executives at Beam Therapeutics Inc?
Jeremy Green is the 10 percent owner of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include Chief Medical Officer Amy Simon , President & CSO Giuseppe Ciaramella , and CFO Terry-ann Burrell .
Beam Therapeutics Inc (BEAM) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Beam Therapeutics Inc (BEAM). Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 114,771 shares made by Terry-ann Burrell , a net sale of 17,788 shares made by Christine Bellon , and a net sale of 215,751 shares made by Giuseppe Ciaramella .
In summary, during the past 3 months, insiders sold 115,170 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 115,170 shares. During the past 18 months, 1,383,256 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,383,256 shares.
Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Beam Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Cabaletta Bio Inc do?
Who are the key executives at Cabaletta Bio Inc?
Jeremy Green is the 10 percent owner of Cabaletta Bio Inc. Other key executives at Cabaletta Bio Inc include EVP & Science & Technology Gwendolyn Binder , director & President & CEO Steven Nichtberger , and Chief Financial Officer Anup Marda .
Cabaletta Bio Inc (CABA) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net sale of 110,000 shares made by Gwendolyn Binder ,
In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110,000 shares of Cabaletta Bio Inc (CABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.
Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cabaletta Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Alder BioPharmaceuticals Inc do?
Who are the key executives at Alder BioPharmaceuticals Inc?
Jeremy Green is the director of Alder BioPharmaceuticals Inc. Other key executives at Alder BioPharmaceuticals Inc include 10 percent owner H Lundbeck A S , Chief Medical Officer Paul Streck , and Chief Financial Officer Carlos Campoy .
Alder BioPharmaceuticals Inc (ALDR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alder BioPharmaceuticals Inc (ALDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alder BioPharmaceuticals Inc (ALDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alder BioPharmaceuticals Inc (ALDR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alder BioPharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
Jeremy Green is the 10 percent owner of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 16,957 shares made by Bernd R. Seizinger , a net purchase of 6,860 shares made by Henneman John B Iii , and a net purchase of 2,000 shares made by Oren Gilad .
In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc (APRE) in total and bought 16,730 shares, with a net purchase of 16,730 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc (APRE) were sold and 26,827 shares were bought by its insiders, resulting in a net purchase of 26,827 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Atreca Inc do?
Who are the key executives at Atreca Inc?
Jeremy Green is the 10 percent owner of Atreca Inc. Other key executives at Atreca Inc include director & Chief Strategy Officer Tito Serafini , other: Former 10% Owner Felix Baker , and other: Former 10% Owner Baker Bros. Advisors Lp .
Atreca Inc (BCEL) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .
In summary, during the past 3 months, insiders sold 20,788 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 20,788 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.
Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atreca Inc Insider Transactions
- Download to Excel(.xls)
What does Akero Therapeutics Inc do?
Who are the key executives at Akero Therapeutics Inc?
Jeremy Green is the 10 percent owner of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include Chief Operating Officer Jonathan Young , director & President & CEO Andrew Cheng , and Chief Development Officer Catriona Yale .
Akero Therapeutics Inc (AKRO) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Akero Therapeutics Inc (AKRO). Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 343,870 shares made by Andrew Cheng , a net sale of 69,475 shares made by Jonathan Young , and a net sale of 77,268 shares made by Catriona Yale .
In summary, during the past 3 months, insiders sold 110,332 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 110,332 shares. During the past 18 months, 2,361,483 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net sale of 1,041,483 shares.
Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akero Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Stoke Therapeutics Inc do?
Who are the key executives at Stoke Therapeutics Inc?
Jeremy Green is the 10 percent owner of Stoke Therapeutics Inc. Other key executives at Stoke Therapeutics Inc include Chief Medical Officer Barry Ticho , 10 percent owner Skorpios Trust , and General Counsel & Corp Sec Jonathan Allan .
Stoke Therapeutics Inc (STOK) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Stoke Therapeutics Inc (STOK). Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 149,116 shares made by Barry Ticho , a net sale of 9,423 shares made by Jonathan Allan , and a net sale of 3,600,000 shares made by Skorpios Trust .
In summary, during the past 3 months, insiders sold 3,650,973 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 3,650,973 shares. During the past 18 months, 3,777,921 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,777,921 shares.
Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stoke Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does HOOKIPA Pharma Inc do?
Who are the key executives at HOOKIPA Pharma Inc?
Jeremy Green is the 10 percent owner of HOOKIPA Pharma Inc. Other key executives at HOOKIPA Pharma Inc include director & Chief Financial Officer Reinhard Kandera , director & Chief Executive Officer Jorn Aldag , and Chief Medical Officer Katia Schlienger .
HOOKIPA Pharma Inc (HOOK) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in HOOKIPA Pharma Inc (HOOK). Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 27,000 shares made by Reinhard Kandera , and a net purchase of 20,000 shares made by Jorn Aldag .
In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 47,000 shares were bought by its insiders, resulting in a net purchase of 47,000 shares.
HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
HOOKIPA Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Jeremy Green is the 10 percent owner of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , See Remarks Shannon John Patrick Jr , and director & See Remarks Paul R Edick .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 16,400 shares made by John P. Schmid , a net purchase of 30,000 shares made by Paul R Edick , and a net purchase of 30,769 shares made by Shannon John Patrick Jr .
In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 9,900 shares, with a net purchase of 9,900 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 115,979 shares were bought by its insiders, resulting in a net purchase of 115,979 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does TCR2 Therapeutics Inc do?
Who are the key executives at TCR2 Therapeutics Inc?
Jeremy Green is the 10 percent owner of TCR2 Therapeutics Inc. Other key executives at TCR2 Therapeutics Inc include 10 percent owner Kevin C Tang , director & 10 percent owner Ansbert Gadicke , and 10 percent owner Mpm Asset Management Llc .
TCR2 Therapeutics Inc (TCRR) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in TCR2 Therapeutics Inc (TCRR). Other recent insider transactions involving TCR2 Therapeutics Inc (TCRR) include a net purchase of 468,513 shares made by Kevin C Tang , a net sale of 82,187 shares made by Garry E Menzel , and a net sale of 32,841 shares made by Alfonso Quintas Cardama .
In summary, during the past 3 months, insiders sold 0 shares of TCR2 Therapeutics Inc (TCRR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 287,401 shares of TCR2 Therapeutics Inc (TCRR) were sold and 468,513 shares were bought by its insiders, resulting in a net purchase of 181,112 shares.
TCR2 Therapeutics Inc (TCRR)'s detailed insider trading history can be found in Insider Trading Tracker table.
TCR2 Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Vapotherm Inc do?
Who are the key executives at Vapotherm Inc?
Jeremy Green is the 10 percent owner of Vapotherm Inc. Other key executives at Vapotherm Inc include director & President and CEO Joseph Army , Chief Accounting Officer Dorota Mckay , and See Remarks John Landry .
Vapotherm Inc (VAPO) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Vapotherm Inc (VAPO). Other recent insider transactions involving Vapotherm Inc (VAPO) include a net purchase of 1,676,190 shares made by Joseph Army , a net purchase of 575,842 shares made by Elizabeth H Weatherman , and a net purchase of 175,500 shares made by Anthony L. Arnerich .
In summary, during the past 3 months, insiders sold 0 shares of Vapotherm Inc (VAPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vapotherm Inc (VAPO) were sold and 594,599 shares were bought by its insiders, resulting in a net purchase of 594,599 shares.
Vapotherm Inc (VAPO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vapotherm Inc Insider Transactions
- Download to Excel(.xls)
What does Gritstone Bio Inc do?
Who are the key executives at Gritstone Bio Inc?
Jeremy Green is the 10 percent owner of Gritstone Bio Inc. Other key executives at Gritstone Bio Inc include See Remarks Vassiliki Economides , See Remarks Erin Jones , and Chief Accounting Officer James Cho .
Gritstone Bio Inc (GRTS) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Gritstone Bio Inc (GRTS). Other recent insider transactions involving Gritstone Bio Inc (GRTS) include a net purchase of 12,000 shares made by Vassiliki Economides ,
In summary, during the past 3 months, insiders sold 0 shares of Gritstone Bio Inc (GRTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Gritstone Bio Inc (GRTS) were sold and 12,000 shares were bought by its insiders, resulting in a net purchase of 12,000 shares.
Gritstone Bio Inc (GRTS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gritstone Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Replimune Group Inc do?
Who are the key executives at Replimune Group Inc?
Jeremy Green is the 10 percent owner of Replimune Group Inc. Other key executives at Replimune Group Inc include Chief Commercial Officer Christopher Sarchi , Chief Medical Officer Konstantinos Xynos , and Chief Financial Officer Emily Luisa Hill .
Replimune Group Inc (REPL) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Replimune Group Inc (REPL). Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 66,624 shares made by Pamela Esposito , a net sale of 25,067 shares made by Tanya Lewis , and a net sale of 21,273 shares made by Sushil Patel .
In summary, during the past 3 months, insiders sold 0 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 174,192 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 174,192 shares.
Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Replimune Group Inc Insider Transactions
- Download to Excel(.xls)
What does Allakos Inc do?
Who are the key executives at Allakos Inc?
Jeremy Green is the 10 percent owner of Allakos Inc. Other key executives at Allakos Inc include Chief Medical Officer Craig A. Paterson , General Counsel and Secretary Margaret Nell Fitzgerald , and COO & CFO and Secretary Adam Tomasi .
Allakos Inc (ALLK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Allakos Inc (ALLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Allakos Inc (ALLK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Allakos Inc (ALLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Allakos Inc Insider Transactions
- Download to Excel(.xls)
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Jeremy Green is the 10 percent owner of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Medical Officer David Roth , Chief Scientific Officer Eric R Olson , and Chief Financial Officer Jason Haas .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net sale of 689 shares made by Eric R Olson .
In summary, during the past 3 months, insiders sold 10,601 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 10,601 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 904,977 shares were bought by its insiders, resulting in a net purchase of 873,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Jeremy Green is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 623,732 shares made by John F Crowley , a net sale of 260,446 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .
In summary, during the past 3 months, insiders sold 75,014 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 75,014 shares. During the past 18 months, 1,222,514 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,222,514 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does MedAvail Holdings Inc do?
Who are the key executives at MedAvail Holdings Inc?
Jeremy Green is the director & 10 percent owner of MedAvail Holdings Inc. Other key executives at MedAvail Holdings Inc include Chief Financial Officer Ramona Seabaugh , director & Chief Executive Officer Mark Edward Doerr , and director & 10 percent owner Redco Ii Master Fund, L.p. .
MedAvail Holdings Inc (MDVLQ) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in MedAvail Holdings Inc (MDVLQ). Other recent insider transactions involving MedAvail Holdings Inc (MDVLQ) include a net sale of 10,317 shares made by Ramona Seabaugh , and a net sale of 93,558 shares made by Mark Edward Doerr .
In summary, during the past 3 months, insiders sold 0 shares of MedAvail Holdings Inc (MDVLQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,875 shares of MedAvail Holdings Inc (MDVLQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 103,875 shares.
MedAvail Holdings Inc (MDVLQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
MedAvail Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Absci Corp do?
Who are the key executives at Absci Corp?
Jeremy Green is the director & 10 percent owner of Absci Corp. Other key executives at Absci Corp include director & 10 percent owner Redmile Group, Llc , General Counsel Sarah Korman , and VP & CCPAO Todd Bedrick .
Absci Corp (ABSI) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Absci Corp (ABSI). Other recent insider transactions involving Absci Corp (ABSI) include a net purchase of 222,222 shares made by Redmile Group, Llc ,
In summary, during the past 3 months, insiders sold 0 shares of Absci Corp (ABSI) in total and bought 222,222 shares, with a net purchase of 222,222 shares. During the past 18 months, 0 shares of Absci Corp (ABSI) were sold and 222,222 shares were bought by its insiders, resulting in a net purchase of 222,222 shares.
Absci Corp (ABSI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Absci Corp Insider Transactions
- Download to Excel(.xls)
What does Entrada Therapeutics Inc do?
Who are the key executives at Entrada Therapeutics Inc?
Jeremy Green is the 10 percent owner of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include Chief Operating Officer Nathan J Dowden , Chief Financial Officer Kory James Wentworth , and director & President and CEO Dipal Doshi .
Entrada Therapeutics Inc (TRDA) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 34,092 shares made by Dipal Doshi , a net sale of 52,696 shares made by Kory James Wentworth , and a net purchase of 45,368 shares made by Peter S Kim .
In summary, during the past 3 months, insiders sold 5,912 shares of Entrada Therapeutics Inc (TRDA) in total and bought 45,368 shares, with a net purchase of 39,456 shares. During the past 18 months, 167,306 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 121,938 shares.
Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entrada Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Augmedix Inc do?
Who are the key executives at Augmedix Inc?
Jeremy Green is the director & 10 percent owner of Augmedix Inc. Other key executives at Augmedix Inc include CHIEF STRATEGY OFFICER Ian Shakil , Chief Financial Officer Paul Ginocchio , and director & 10 percent owner Redmile Group, Llc .
Augmedix Inc (AUGX) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Augmedix Inc (AUGX). Other recent insider transactions involving Augmedix Inc (AUGX) include a net sale of 473,388 shares made by Ian Shakil , a net purchase of 28,000 shares made by Paul Ginocchio , and a net sale of 2,410,000 shares made by Mckesson Ventures, Llc .
In summary, during the past 3 months, insiders sold 473,388 shares of Augmedix Inc (AUGX) in total and bought 0 shares, with a net sale of 473,388 shares. During the past 18 months, 2,883,388 shares of Augmedix Inc (AUGX) were sold and 1,554,530 shares were bought by its insiders, resulting in a net sale of 1,328,858 shares.
Augmedix Inc (AUGX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Augmedix Inc Insider Transactions
- Download to Excel(.xls)
What does Science 37 Holdings Inc do?
Who are the key executives at Science 37 Holdings Inc?
Jeremy Green is the director & 10 percent owner of Science 37 Holdings Inc. Other key executives at Science 37 Holdings Inc include Chief Technology Officer Troy Bryenton , Chief Legal Officer Christine A Pellizzari , and Chief Commercial Officer Michael Shipton .
Science 37 Holdings Inc (SNCE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Science 37 Holdings Inc (SNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Science 37 Holdings Inc (SNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Science 37 Holdings Inc (SNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Science 37 Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Invivyd Inc do?
Who are the key executives at Invivyd Inc?
Jeremy Green is the 10 percent owner of Invivyd Inc. Other key executives at Invivyd Inc include 10 percent owner & other: See Remarks Adimab, Llc , Chief Financial Officer William E. Duke , and Chief Scientific Officer Allen Robert D. Iii .
Invivyd Inc (IVVD) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Invivyd Inc (IVVD). Other recent insider transactions involving Invivyd Inc (IVVD) include a net sale of 5,000,000 shares made by Adimab, Llc ,
In summary, during the past 3 months, insiders sold 0 shares of Invivyd Inc (IVVD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,000,000 shares of Invivyd Inc (IVVD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,000,000 shares.
Invivyd Inc (IVVD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Invivyd Inc Insider Transactions
- Download to Excel(.xls)
What does Verve Therapeutics Inc do?
Who are the key executives at Verve Therapeutics Inc?
Jeremy Green is the 10 percent owner of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include See Remarks Andrew D. Ashe , Chief Administrative Officer Joan Nickerson , and director & 10 percent owner Krishna Yeshwant .
Verve Therapeutics Inc (VERV) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net sale of 1,108 shares made by Allison Dorval , a net purchase of 1,800,000 shares made by Krishna Yeshwant , and a net purchase of 76,000 shares made by Andrew D. Ashe .
In summary, during the past 3 months, insiders sold 1,514 shares of Verve Therapeutics Inc (VERV) in total and bought 76,000 shares, with a net purchase of 74,486 shares. During the past 18 months, 3,487 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,872,513 shares.
Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verve Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Zymeworks Inc do?
Who are the key executives at Zymeworks Inc?
Jeremy Green is the 10 percent owner of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , SVP & Chief Financial Officer Christopher Astle , and Chief Scientific Officer Paul Andrew Moore .
Zymeworks Inc (ZYME) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net purchase of 5,868,900 shares made by Ecor1 Capital, Llc , a net sale of 8,654 shares made by Christopher Astle , and a net sale of 23,904 shares made by Kenneth Galbraith .
In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,334 shares of Zymeworks Inc (ZYME) were sold and 5,868,900 shares were bought by its insiders, resulting in a net purchase of 5,823,566 shares.
Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zymeworks Inc Insider Transactions
- Download to Excel(.xls)
What does RayzeBio inc do?
Who are the key executives at RayzeBio inc?
Jeremy Green is the 10 percent owner of RayzeBio inc. Other key executives at RayzeBio inc include 10 percent owner Viking Global Investors Lp , 10 percent owner Viking Global Opportunities Drawdown (aggregator) Lp , and 10 percent owner Goodman Corey S .
RayzeBio inc (RYZB) Insider Trades Summary
Over the past 18 months, Jeremy Green made no insider transaction in RayzeBio inc (RYZB). Other recent insider transactions involving RayzeBio inc (RYZB) include a net purchase of 2,777,778 shares made by Viking Global Investors Lp , and a net purchase of 472,222 shares made by Maha Katabi .
In summary, during the past 3 months, insiders sold 0 shares of RayzeBio inc (RYZB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RayzeBio inc (RYZB) were sold and 3,250,000 shares were bought by its insiders, resulting in a net purchase of 3,250,000 shares.
RayzeBio inc (RYZB)'s detailed insider trading history can be found in Insider Trading Tracker table.
RayzeBio inc Insider Transactions
- Download to Excel(.xls)
Jeremy Green Mailing Address
Above is the net worth, insider trading, and ownership report for Jeremy Green. You might contact Jeremy Green via mailing address: 45 W. 27th Street, Floor 11, New York Ny 10001.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey